These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7618663)

  • 21. Response to atracurium and mivacurium in a patient with Charcot-Marie-Tooth disease.
    Naguib M; Samarkandi AH
    Can J Anaesth; 1998 Jan; 45(1):56-9. PubMed ID: 9466029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug.
    Savarese JJ; Ali HH; Basta SJ; Embree PB; Scott RP; Sunder N; Weakly JN; Wastila WB; el-Sayad HA
    Anesthesiology; 1988 May; 68(5):723-32. PubMed ID: 2967039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mivacurium--a new muscle relaxant compared with atracurium and vecuronium].
    Scholz J; von Knobelsdorff G; Peters K; Kycia B; Schulte am Esch J
    Anaesthesiol Reanim; 1997; 22(4):95-9. PubMed ID: 9376044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of the duration of control stimulation on the onset and recovery of neuromuscular block.
    McCoy EP; Mirakhur RK; Connolly FM; Loan PB
    Anesth Analg; 1995 Feb; 80(2):364-7. PubMed ID: 7818125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuromuscular and hemodynamic effects of mivacurium and succinylcholine in adult patients during nitrous oxide-propofol-fentanyl anesthesia.
    Hwang KH; Kim SC; Kim SY; Ueda N; Muteki T
    J Korean Med Sci; 1993 Oct; 8(5):374-9. PubMed ID: 8305145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nondepolarizing neuromuscular blocking drugs and train-of-four fade.
    McCoy EP; Connolly FM; Mirakhur RK; Loan PB; Paxton LD
    Can J Anaesth; 1995 Mar; 42(3):213-6. PubMed ID: 7743572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antagonism of mivacurium-induced neuromuscular blockade in humans. Edrophonium dose requirements at threshold train-of-four count of 4.
    Kopman AF; Mallhi MU; Justo MD; Rodricks P; Neuman GG
    Anesthesiology; 1994 Dec; 81(6):1394-400. PubMed ID: 7992908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The reversal of profound mivacurium-induced neuromuscular blockade.
    Kao YJ; Le ND
    Can J Anaesth; 1996 Nov; 43(11):1128-33. PubMed ID: 8922768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose mivacurium supplementation of prilocaine i.v. regional anaesthesia.
    Torrance JM; Lewer BM; Galletly DC
    Br J Anaesth; 1997 Feb; 78(2):222-3. PubMed ID: 9068344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and pharmacodynamics of the benzylisoquinolinium muscle relaxants.
    Hull CJ
    Acta Anaesthesiol Scand Suppl; 1995; 106():13-7. PubMed ID: 8533537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The onset of rocuronium, but not of vecuronium or mivacurium, is modified by tourniquet inflation.
    Audibert G; Donati F
    Anesth Analg; 1996 Apr; 82(4):848-53. PubMed ID: 8615509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Course of the neuromuscular block under atracurium. Comparison with alcuronium].
    Deschodt J; Jullien Y; Lubrano JF; Roussel-Monfajon D; du Cailar J
    Ann Fr Anesth Reanim; 1985; 4(6):477-83. PubMed ID: 2936286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of train-of-four stimulation influences neuromuscular response.
    Meretoja OA; Taivainen T; Brandom BW; Wirtavuori K
    Br J Anaesth; 1994 Jun; 72(6):686-7. PubMed ID: 7912949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuromuscular pharmacodynamics of mivacurium in adults with major burns.
    Han TH; Martyn JA
    Br J Anaesth; 2011 May; 106(5):675-9. PubMed ID: 21354998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neostigmine but not edrophonium prolongs the action of mivacurium.
    Symington MJ; Mirakhur RK; Kumar N
    Can J Anaesth; 1996 Dec; 43(12):1220-3. PubMed ID: 8955970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The infusion rate of mivacurium or atracurium for cesarean section compared with gynecological procedures.
    Kim JH; Min KT; Ahn EK; Kim KH; Shin YS
    Yonsei Med J; 1999 Aug; 40(4):371-6. PubMed ID: 10487141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey.
    de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
    Br J Anaesth; 2006 Apr; 96(4):473-9. PubMed ID: 16464982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacology of mivacurium chloride: a review.
    Basta SJ
    J Clin Anesth; 1992; 4(2):153-63. PubMed ID: 1373287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histamine-release haemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine.
    Naguib M; Samarkandi AH; Bakhamees HS; Magboul MA; el-Bakry AK
    Br J Anaesth; 1995 Nov; 75(5):588-92. PubMed ID: 7577286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical pharmacology of GW280430A (AV430A) in the rhesus monkey and in the cat: a comparison with mivacurium.
    Savarese JJ; Belmont MR; Hashim MA; Mook RA; Boros EE; Samano V; Patel SS; Feldman PL; Schultz JA; McNulty M; Spitzer T; Cohn DL; Morgan P; Wastila WB
    Anesthesiology; 2004 Apr; 100(4):835-45. PubMed ID: 15087618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.